Formation Bio Stock

www.formation.bioHealthcare / BioTech & PharmaFounded: 2013Funding to Date: $615.78MM

Formation Bio is a pharmaceutical company that uses AI aiming to streamline and accelerate the development of drug treatments. Formation Bio was founded in 2016 and is headquartered in New York, NY. The company strives to address key limitations in the traditional drug development process by seeking to expedite drug development rather than focusing on the discovery of new treatments. Formation Bio partners with biotech and pharmaceutical companies to acquire and co-develop clinical-stage drug candidates, with the goal of reaching patients faster.

Register To Buy and Sell Shares

For more details on financing and valuation for Formation Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Formation Bio’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Formation Bio.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Formation Bio investors also invested in these private companies

Dragoneer Investment Group
TQ Ventures
Cherubic Ventures

Team

Management Team

Ben Liu
Co-Founder & Chief Executive Officer
Linhao Zhang
Co-Founder & Chief Technology Officer
Gavin Corcoran MD
Chief Development Officer
James Leslie
Chief Financial Officer
Melissa Enbar
Chief People Officer

Board Members

Alfred Lin
Sequoia Capital
Scott Kupor JD
Andreessen Horowitz

Formation Bio’s stock FAQs

plusminus

Can you buy Formation Bio’s stock?

Formation Bio is not publicly traded on NYSE or NASDAQ in the U.S. To buy Formation Bio’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell Formation Bio’s stock?

Yes, you can sell stock of a private company like Formation Bio. Forge can help you sell your Formation Bio stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus

What is Formation Bio’s stock price?

Formation Bio is a privately held company and therefore does not have a public stock price. However, you may access Formation Bio’s private market stock price with Forge Data.
plusminus

What is Formation Bio’s stock ticker symbol?

Formation Bio does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Formation Bio raises $372M to boost drug development with AI

In a Series D funding round led by Andreessen Horowitz, Formation Bio raised $372 million.

23andMe and TrialSpark Announce Joint Clinical Trial Offering and Request For Proposals

NEW YORK, Sept. 26, 2019 /PRNewswire/ -- 23andMe, the leading consumer genetics company, and TrialSpark, a technology company enabling physician practices to...

23andMe's new deal with TrialSpark looks to clinical trial recruitment

The partners announced that they are putting out a request for clinical trial proposals in the areas of dermatology, gastroenterology, pulmonology, endocrinology, ophthalmology, inflammatory diseases, neurology, women’s health and rare diseases.
Updated on: Jul 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.